Sensitive detection of proteopathic seeding activity with FRET flow cytometry

Jennifer L. Furman, Brandon B. Holmes, Marc I. Diamond

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Increasing evidence supports transcellular propagation of toxic protein aggregates, or proteopathic seeds, as a mechanism for the initiation and progression of pathology in several neurodegenerative diseases, including Alzheimer’s disease and the related tauopathies. The potentially critical role of tau seeds in disease progression strongly supports the need for a sensitive assay that readily detects seeding activity in biological samples. By combining the specificity of fluorescence resonance energy transfer (FRET), the sensitivity of flow cytometry, and the stability of a monoclonal cell line, an ultra-sensitive seeding assay has been engineered and is compatible with seed detection from recombinant or biological samples, including human and mouse brain homogenates. The assay employs monoclonal HEK 293T cells that stably express the aggregation-prone repeat domain (RD) of tau harboring the disease-associated P301S mutation fused to either CFP or YFP, which produce a FRET signal upon protein aggregation. The uptake of proteopathic tau seeds (but not other proteins) into the biosensor cells stimulates aggregation of RD- CFP and RD-YFP, and flow cytometry sensitively and quantitatively monitors this aggregation-induced FRET. The assay detects femtomolar concentrations (monomer equivalent) of recombinant tau seeds, has a dynamic range spanning three orders of magnitude, and is compatible with brain homogenates from tauopathy transgenic mice and human tauopathy subjects. With slight modifications, the assay can also detect seeding activity of other proteopathic seeds, such as a-synuclein, and is also compatible with primary neuronal cultures. The ease, sensitivity, and broad applicability of FRET flow cytometry makes it useful to study a wide range of protein aggregation disorders.

Original languageEnglish (US)
Article numbere53205
JournalJournal of Visualized Experiments
Volume2015
Issue number106
DOIs
StatePublished - Dec 8 2015

Fingerprint

Fluorescence Resonance Energy Transfer
Flow cytometry
Seed
Seeds
Flow Cytometry
Tauopathies
Assays
Agglomeration
Proteins
Brain
Synucleins
Neurodegenerative diseases
Cell Aggregation
HEK293 Cells
Poisons
Biosensing Techniques
Pathology
Biosensors
Neurodegenerative Diseases
Transgenic Mice

Keywords

  • Bioengineering
  • Flow cytometry
  • FRET
  • Huntingtin
  • Issue 106
  • Neurodegeneration
  • Prion
  • Protein aggregation
  • Seeding
  • Synuclein
  • Tau
  • Transcellular propagation

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Chemical Engineering(all)
  • Immunology and Microbiology(all)
  • Neuroscience(all)

Cite this

Sensitive detection of proteopathic seeding activity with FRET flow cytometry. / Furman, Jennifer L.; Holmes, Brandon B.; Diamond, Marc I.

In: Journal of Visualized Experiments, Vol. 2015, No. 106, e53205, 08.12.2015.

Research output: Contribution to journalArticle

@article{5291501c134940aa8038d25817769329,
title = "Sensitive detection of proteopathic seeding activity with FRET flow cytometry",
abstract = "Increasing evidence supports transcellular propagation of toxic protein aggregates, or proteopathic seeds, as a mechanism for the initiation and progression of pathology in several neurodegenerative diseases, including Alzheimer’s disease and the related tauopathies. The potentially critical role of tau seeds in disease progression strongly supports the need for a sensitive assay that readily detects seeding activity in biological samples. By combining the specificity of fluorescence resonance energy transfer (FRET), the sensitivity of flow cytometry, and the stability of a monoclonal cell line, an ultra-sensitive seeding assay has been engineered and is compatible with seed detection from recombinant or biological samples, including human and mouse brain homogenates. The assay employs monoclonal HEK 293T cells that stably express the aggregation-prone repeat domain (RD) of tau harboring the disease-associated P301S mutation fused to either CFP or YFP, which produce a FRET signal upon protein aggregation. The uptake of proteopathic tau seeds (but not other proteins) into the biosensor cells stimulates aggregation of RD- CFP and RD-YFP, and flow cytometry sensitively and quantitatively monitors this aggregation-induced FRET. The assay detects femtomolar concentrations (monomer equivalent) of recombinant tau seeds, has a dynamic range spanning three orders of magnitude, and is compatible with brain homogenates from tauopathy transgenic mice and human tauopathy subjects. With slight modifications, the assay can also detect seeding activity of other proteopathic seeds, such as a-synuclein, and is also compatible with primary neuronal cultures. The ease, sensitivity, and broad applicability of FRET flow cytometry makes it useful to study a wide range of protein aggregation disorders.",
keywords = "Bioengineering, Flow cytometry, FRET, Huntingtin, Issue 106, Neurodegeneration, Prion, Protein aggregation, Seeding, Synuclein, Tau, Transcellular propagation",
author = "Furman, {Jennifer L.} and Holmes, {Brandon B.} and Diamond, {Marc I.}",
year = "2015",
month = "12",
day = "8",
doi = "10.3791/53205",
language = "English (US)",
volume = "2015",
journal = "Journal of Visualized Experiments",
issn = "1940-087X",
publisher = "MYJoVE Corporation",
number = "106",

}

TY - JOUR

T1 - Sensitive detection of proteopathic seeding activity with FRET flow cytometry

AU - Furman, Jennifer L.

AU - Holmes, Brandon B.

AU - Diamond, Marc I.

PY - 2015/12/8

Y1 - 2015/12/8

N2 - Increasing evidence supports transcellular propagation of toxic protein aggregates, or proteopathic seeds, as a mechanism for the initiation and progression of pathology in several neurodegenerative diseases, including Alzheimer’s disease and the related tauopathies. The potentially critical role of tau seeds in disease progression strongly supports the need for a sensitive assay that readily detects seeding activity in biological samples. By combining the specificity of fluorescence resonance energy transfer (FRET), the sensitivity of flow cytometry, and the stability of a monoclonal cell line, an ultra-sensitive seeding assay has been engineered and is compatible with seed detection from recombinant or biological samples, including human and mouse brain homogenates. The assay employs monoclonal HEK 293T cells that stably express the aggregation-prone repeat domain (RD) of tau harboring the disease-associated P301S mutation fused to either CFP or YFP, which produce a FRET signal upon protein aggregation. The uptake of proteopathic tau seeds (but not other proteins) into the biosensor cells stimulates aggregation of RD- CFP and RD-YFP, and flow cytometry sensitively and quantitatively monitors this aggregation-induced FRET. The assay detects femtomolar concentrations (monomer equivalent) of recombinant tau seeds, has a dynamic range spanning three orders of magnitude, and is compatible with brain homogenates from tauopathy transgenic mice and human tauopathy subjects. With slight modifications, the assay can also detect seeding activity of other proteopathic seeds, such as a-synuclein, and is also compatible with primary neuronal cultures. The ease, sensitivity, and broad applicability of FRET flow cytometry makes it useful to study a wide range of protein aggregation disorders.

AB - Increasing evidence supports transcellular propagation of toxic protein aggregates, or proteopathic seeds, as a mechanism for the initiation and progression of pathology in several neurodegenerative diseases, including Alzheimer’s disease and the related tauopathies. The potentially critical role of tau seeds in disease progression strongly supports the need for a sensitive assay that readily detects seeding activity in biological samples. By combining the specificity of fluorescence resonance energy transfer (FRET), the sensitivity of flow cytometry, and the stability of a monoclonal cell line, an ultra-sensitive seeding assay has been engineered and is compatible with seed detection from recombinant or biological samples, including human and mouse brain homogenates. The assay employs monoclonal HEK 293T cells that stably express the aggregation-prone repeat domain (RD) of tau harboring the disease-associated P301S mutation fused to either CFP or YFP, which produce a FRET signal upon protein aggregation. The uptake of proteopathic tau seeds (but not other proteins) into the biosensor cells stimulates aggregation of RD- CFP and RD-YFP, and flow cytometry sensitively and quantitatively monitors this aggregation-induced FRET. The assay detects femtomolar concentrations (monomer equivalent) of recombinant tau seeds, has a dynamic range spanning three orders of magnitude, and is compatible with brain homogenates from tauopathy transgenic mice and human tauopathy subjects. With slight modifications, the assay can also detect seeding activity of other proteopathic seeds, such as a-synuclein, and is also compatible with primary neuronal cultures. The ease, sensitivity, and broad applicability of FRET flow cytometry makes it useful to study a wide range of protein aggregation disorders.

KW - Bioengineering

KW - Flow cytometry

KW - FRET

KW - Huntingtin

KW - Issue 106

KW - Neurodegeneration

KW - Prion

KW - Protein aggregation

KW - Seeding

KW - Synuclein

KW - Tau

KW - Transcellular propagation

UR - http://www.scopus.com/inward/record.url?scp=84952845533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952845533&partnerID=8YFLogxK

U2 - 10.3791/53205

DO - 10.3791/53205

M3 - Article

C2 - 26710240

AN - SCOPUS:84952845533

VL - 2015

JO - Journal of Visualized Experiments

JF - Journal of Visualized Experiments

SN - 1940-087X

IS - 106

M1 - e53205

ER -